Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59
-$136 QoQ
Shares Held
9
-43.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MAI Capital Management holds $463,973,037 across 18 Drug Manufacturers - General names. SCLX ranks #18 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
548,990 | $134,195,115 | |
| 2 | ABBV |
AbbVie Inc.
|
577,833 | $125,672,899 | |
| 3 | LLY |
ELI LILLY & Co
|
96,089 | $88,379,779 | |
| 4 | MRK |
Merck & Co., Inc.
|
335,023 | $40,299,916 | |
| 5 | AMGN |
Amgen Inc
|
87,280 | $30,709,468 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
223,761 | $13,571,104 | |
| 7 | PFE |
Pfizer Inc
|
420,692 | $11,813,031 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
44,349 | $6,180,920 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59 | 9 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $195 | 16 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $354 | 18 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $106 | 18 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||